Sectors
Johnson & Johnson to buy private drug developer for $1.75 billion
Johnson & Johnson (JNJ.N) agreed to pay $1.75 billion in cash to buy privately held Alios BioPharma Inc, which is developing a drug for a common respiratory viral infection in children for which there is no approved treatment.
EBay follows Icahn's advice, plans PayPal spinoff in 2015
EBay Inc's agreement on Tuesday to spin off PayPal next year will give the unit more flexibility to strike deals in the rapidly evolving payments space as growth at the company's traditional e-commerce business slows.
SRR Advises on Sale of Engineered Polymers Corp.
Stout Risius Ross, Inc. (SRR) announced today that its client, Engineered Polymers Corp. ("EPC"), has been acquired by Imperial Plastics, Incorporated ("Imperial"), a portfolio company of Goldner Hawn Johnson & Morrison Incorporated ("GHJM"). SRR served as exclusive financial advisor to EPC in connection with this transaction.
Big Shift in China's Consumer Economy Impacts Its Role Providing Cheap Consumer Goods on the Worldwide Stage
China's growing consumer economy will lead to rise in prices and eventually reduce its role as the supplier of cheap consumer goods to the world.